ClinicalTrials.Veeva

Menu

Effects on Glucose Homeostasis of Changes in Plasma Lipoproteins Induced by Nutritional and Pharmacologic Strategies

A

Azienda Ospedaliero, Universitaria Pisana

Status

Invitation-only

Conditions

Glucose Metabolism Disorders

Treatments

Dietary Supplement: Intermittent Fasting
Dietary Supplement: Low-Carbohydrate/High-Protein diet
Drug: Fibrates

Study type

Interventional

Funder types

Other

Identifiers

NCT05213988
GLUCO-STAR

Details and patient eligibility

About

The investigators aim to examine the impact of changes in plasma lipoproteins induced by nutritional and pharmacological interventions on glucose homeostasis

Enrollment

50 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 18-65 years
  • both males and females

Exclusion criteria

  • acute or chronic conditions influencing glucose and lipid metabolism
  • pregnancy

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 4 patient groups

Low-Carbohydrate/High-Protein Diet
Experimental group
Treatment:
Dietary Supplement: Low-Carbohydrate/High-Protein diet
Fibrate
Experimental group
Treatment:
Drug: Fibrates
Intermittent Fasting
Experimental group
Treatment:
Dietary Supplement: Intermittent Fasting
Control
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems